METHODS: We performed a retrospective study involving 112 patients diagnosed with CU. Demographic and clinical variables were collected. The etiology of CU was classified using the EAACI/GA2LEN/EDF/WAO guideline. Descriptive analyses were performed for demographical and clinical variables. Chi square tests were applied to analyze the fit of distribution and the independence of variables. P values less than 0.05 were considered significant.
RESULTS: Among all the patients, 76.8% were diagnosed with chronic spontaneous urticaria (CSU), of which 22.3% had a known etiology, being food associated urticaria the most common (10.7%) (p<0.01). On the other hand, 23.2% inducible urticarias (CIndU) were indetified, where dermographism was the most common (10.7%) (p<0.01).
Regarding treatment regimens, sg-H1-antihistamines alone represented the highest proportion prescribe (44.6%). The combination of any H1-antihistamine plus other drug was a close second (42.0%) (p<0.01). Almost 48% of CSUs of unknown etiology were treated with any antihistamine plus another drug. In patients with known etiology, sg-H1-antihistamines alone (44.0%) was the most common management. In addition, 53.8% of CIndUs were treated with sg-antihistamines alone. Though, these associations were not statistically significant.
CONCLUSIONS: CSU is the most frequent subtype of CU. Modern non-sedating antihistamines in licensed doses are the drug of choice. Nevertheless, a great proportion of patients require the addition of another type of medication.